Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Partial Onset”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01457989
What this trial is testing

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 1
Testing effectiveness (Phase 2)Study completedNCT01527513
What this trial is testing

Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 123
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Not applicableStudy completedNCT01098162
What this trial is testing

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug

Who this might be right for
Epilepsies, Partial
UCB Pharma GmbH 576
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Study completedNCT00490035
What this trial is testing

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma SA 399
Large-scale testing (Phase 3)Study completedNCT00520741
What this trial is testing

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 426
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213
What this trial is testing

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Who this might be right for
Focal Onset Seizure
SK Life Science, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT01866111
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 437
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Testing effectiveness (Phase 2)WithdrawnNCT00982787
What this trial is testing

Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy

Who this might be right for
Partial Epilepsy
Oregon Health and Science University
Large-scale testing (Phase 3)Study completedNCT00280696
What this trial is testing

Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Japan Co. Ltd. 352
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Study completedNCT01243177
What this trial is testing

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Who this might be right for
EpilepsyMonotherapy
UCB BIOSCIENCES GmbH 888
Large-scale testing (Phase 3)Active Not RecruitingNCT06309966
What this trial is testing

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Testing effectiveness (Phase 2)Ended earlyNCT03370120
What this trial is testing

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Who this might be right for
Drug-Resistant EpilepsyFocal-Onset Seizures
UCB Biopharma SRL 406
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Large-scale testing (Phase 3)Study completedNCT01484977
What this trial is testing

EValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

Who this might be right for
Epilepsy
UCB Pharma 120
Next Page